This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Pramipexole |
| Description |
Pramipexole is used alone or with other medications to treat the symptoms of Parkinson's disease (PD). Pramipexole is also used to treat restless legs syndrome (RLS; a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down). Pramipexole is in a class of medications called dopamine |
| Therapeutic Low |
0.0005 |
| Therapeutic High |
0.0063 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
6.00 |
| Half Life High |
12.00 |
| VOD Low |
6.70 |
| VOD High |
7.70 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
|